Intravenous immunoglobulin (IVIG) is a type of medication used to treat people with immunodeficiencies, when the immune ...

This pilot clinical trial evaluated safety and tolerability of intravenous immunoglobulin ... Interventions included monthly infusions of the IVIG preparation Privigen®, dose 0.4 gram/kg ...

The FDA has approved the sBLA for once every 4 weeks lecanemab-irmb (Leqembi®) intravenous maintenance dosing.

Due to the autoimmune etiology of this disorder, IV immunoglobulin (IVIg) or plasma exchange (PE) are the first-line treatments in addition to management of ventilatory failure. IVIg is more ...

In conclusion, we consider that the available data indicate that IVIg is not a lost cause for the therapy of MS 15,16, and that clinical trials are therefore warranted to determine if a ...

Recently, AAP guidelines recommended high-dose IVIg as an alternative to exchange transfusion (EXT). The aim of this study was to compare clinical outcome of RHD patients before and after the ...

This new immunoglobulin (Ig) therapeutic option will expand AIC’s ability to better serve PI patients. “We are excited to add ALGYLO™ to our expansive list of Ig infusion therapies,” said ...